Liver Dysfunction Clinical Trial
Official title:
Effect of Korea Red Ginseng on Non-alcoholic Fatty Liver Disease
| NCT number | NCT03945123 |
| Other study ID # | RIVER |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 1, 2018 |
| Est. completion date | December 31, 2018 |
| Verified date | May 2019 |
| Source | Chuncheon Sacred Heart Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Korea Red Ginseng (KRG) has effect on liver function
| Status | Completed |
| Enrollment | 94 |
| Est. completion date | December 31, 2018 |
| Est. primary completion date | December 31, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 37 Years to 63 Years |
| Eligibility |
Inclusion Criteria: - AST or ALT level > 50 IU/L Exclusion Criteria: - Viral hepatitis - Alcoholic hepatitis - Autoimmune hepatitis - Pancreatitis - Hemochromatosis - Wilson's disease - Drug induced liver injury - Cancer |
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | ChuncheonSHH | Chuncheon | Kangwon |
| Lead Sponsor | Collaborator |
|---|---|
| Chuncheon Sacred Heart Hospital |
Korea, Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Liver enzyme | Decrease liver enzyme level | 1year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02754219 -
Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction
|
Phase 1 | |
| Terminated |
NCT01079104 -
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
|
N/A | |
| Recruiting |
NCT00553553 -
Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery
|
N/A | |
| Completed |
NCT03641872 -
A Validation Cohort for ACLF Diagnosis and Prognosis
|
||
| Completed |
NCT03371537 -
Study of Hemodynamic Conditions Measured During Hepatectomy
|
||
| Not yet recruiting |
NCT05559242 -
Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients
|
Phase 1 | |
| Recruiting |
NCT02473601 -
Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
|
Phase 2 | |
| Completed |
NCT01000337 -
Markers of Liver Apoptosis After Anesthesia With Sevoflurane or Propofol
|
N/A | |
| Completed |
NCT03155984 -
Optimizing HBV Management During Anti-CD20 Antibodies
|
||
| Recruiting |
NCT06126419 -
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
|
N/A | |
| Completed |
NCT03515980 -
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
|
Phase 1 | |
| Completed |
NCT01338714 -
The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function
|
Phase 3 | |
| Completed |
NCT02005744 -
A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function
|
Phase 1 | |
| Completed |
NCT01367522 -
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
|
Phase 1 | |
| Recruiting |
NCT03805139 -
Role of Ajwa Derived Polyphenols in Dyslipidaemias
|
N/A | |
| Enrolling by invitation |
NCT05082077 -
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
|
||
| Completed |
NCT02949505 -
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation
|
N/A | |
| Completed |
NCT02991339 -
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
|
Phase 2/Phase 3 | |
| Completed |
NCT02992639 -
Weight Loss Effect on Circulating Liver Enzymes
|
N/A | |
| Recruiting |
NCT05793203 -
Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
|